Grants and funders

We are grateful for the support of numerous funders who make the work of the Lochmüller Lab possible.


Hanns holds the Canada Research Chair in Neuromuscular Genomics and Health and our lab’s work is supported by funding from the Canada Research Chairs program.


We are supported by a CIHR Foundation Grant on Precision Health for Neuromuscular Diseases under grant no. FDN-167281 and by a CIHR Network Catalyst Grant (jointly funded by Muscular Dystrophy Canada) for NMD4C, a neuromuscular network for Canada, under grant no. NG2-170044. Rachel Thompson holds a CIHR postdoctoral fellowship award under grant no. MFE-171275.


The Canada Foundation for Innovation (CFI) supports equipment in our lab as part of the CRC award.


We are supported by Muscular Dystrophy Canada with a Network Catalyst Grant for NMD4C, a neuromuscular network for Canada (jointly funded by CIHR).


Emily O'Connor's work is supported by a stipend from the French Muscular Dystrophy Association (AFM-Téléthon)

University of Ottawa logo

Stephen Holland is the recipient of an Ontario Graduate Scholarship (OGS) for the 2022-2023 academic year. OGS are merit-based scholarships available to students in all disciplines of academic study.


Read next...

Congratulations to the four funding award recipients!

Four Research Lab Members Receive Funding Awards

We are excited to share that four of our research team members have received competitive funding awards to support their projects. Academic awards for individual trainees not only provide vital...
Welcome to the team - new members of the Lochmuller Lab

Meet the lab’s new clinical members

Our lab is growing! We are excited to introduce several new clinical research staff members who have joined the Lochmüller lab since our last update, and to welcome Dr Hugh...

$109 million to fund Brain-Heart Interconnectome project to study brain-heart disorders

The CHEO Research Institute and the Lochmüller research group are excited to participate in a new uOttawa-led initiative funded by the Canada First Research Excellence Fund (CFREF) to establish a...

8.8 million euros for accelerated drug repurposing for rare neurological disorders

International SIMPATHIC Consortium receives grant from European Commission The Children’s Hospital of Eastern Ontario Research Institute (CHEO RI) has received funding from the New Frontiers in Research Fund (NFRF) -...
The new clinical trials list provides searchable and filterable information on the current trials the research team are conducting.

Lochmuller Lab clinical research webpage update

It’s now easier than ever to stay up-to-date on the clinical research trials that our team is involved in We are excited to share an update to the clinical research...
Periostin paper image

New publication: Periostin as a blood biomarker of muscle cell fibrosis, cardiomyopathy and disease severity in myotonic dystrophy type 1

Lochmüller Lab members published as authors in Journal of Neurology study Myotonic dystrophy is the most common adult-onset muscular dystrophy and affects cardiac and endocrine systems and the central nervous...